selenium has been researched along with thioacetamide in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Abdulla, M; Bengmark, S; Dashti, H; Hägerstrand, I; Jeppsson, B; Srinivas, U | 1 |
Al-Bader, AA; Dashti, HM; Hussain, TA; Mosawi, MH | 1 |
Abul, H; Al-Bader, A; Al-Moosawi, M; Dashti, H; Hussain, T; Mathew, TC | 1 |
Wang, H; Yu, H; Zhang, J | 1 |
Abdelghany, AM; El Gayar, AM; Mohamed, AA; Zaghloul, RA | 1 |
Abdel-Hamed, AR; Abo-Elmatty, DM; Abulsoud, AI; Al-Noshokaty, TM; Mesbah, NM | 1 |
6 other study(ies) available for selenium and thioacetamide
Article | Year |
---|---|
Changes in the plasma levels of copper, zinc, calcium, magnesium and selenium in thioacetamide induced liver cirrhosis.
Topics: Animals; Calcium; Copper; Liver Cirrhosis, Experimental; Magnesium; Male; Rats; Selenium; Thioacetamide; Trace Elements; Zinc | 1986 |
Effect of dietary selenium, zinc and allopurinol supplements on plasma and tissue manganese levels in rats with thioacetamide [correction of thiocetamide]-induced liver cirrhosis.
Topics: Allopurinol; Animal Feed; Animals; Dietary Supplements; Kidney; Liver; Liver Cirrhosis, Experimental; Lung; Male; Manganese; Rats; Rats, Wistar; Selenium; Spleen; Thioacetamide; Tissue Distribution; Zinc | 1997 |
Selenium and liver cirrhosis.
Topics: Animals; Liver; Liver Cirrhosis, Experimental; Male; Rats; Rats, Wistar; Selenium; Thioacetamide | 1998 |
Thioacetamide-induced cirrhosis in selenium-adequate mice displays rapid and persistent abnormity of hepatic selenoenzymes which are mute to selenium supplementation.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biological Availability; Diet; Dietary Supplements; Glutathione Peroxidase; Liver; Liver Cirrhosis; Male; Mice; Oxidative Stress; Selenium; Thioacetamide; Thioredoxin-Disulfide Reductase; Thioredoxins | 2007 |
Selenium nanoparticles and quercetin suppress thioacetamide-induced hepatocellular carcinoma in rats: Attenuation of inflammation involvement.
Topics: alpha-Fetoproteins; Animals; beta Catenin; Carcinoma, Hepatocellular; Cyclin D1; Inflammation; Interleukin-33; Interleukin-6; Liver; Liver Neoplasms; Male; Nanoparticles; Oxidative Stress; Quercetin; Rats; Rats, Sprague-Dawley; Selenium; Thioacetamide; Tumor Suppressor Protein p53 | 2022 |
Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and LncRNA-AF085935/GPC3 axis.
Topics: Animals; Antineoplastic Agents; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Glypicans; Liver Neoplasms; Mammals; Nanoparticles; NF-kappa B; Proto-Oncogene Proteins c-akt; Rats; RNA, Long Noncoding; Selenium; Sorafenib; Thioacetamide; TOR Serine-Threonine Kinases | 2022 |